Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Radiographic and Clinical Study Evaluating a Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem Cells (Trinity Evolution™ Viable Cryopreserved Cellular Bone Matrix) in Patients Undergoing Anterior Cervical Discectomy and Fusion

NCT00951938 is registered in ClinicalTrials.gov with Orthofix Inc. as lead sponsor.

NCT NCT00951938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00951938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Radiographic and Clinical Study Evaluating a Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem Cells (Trinity Evolution™ Viable Cryopreserved Cellular Bone Matrix) in Patients Undergoing Anterior Cervical Discectomy and Fusion
Lead sponsor
Orthofix Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
August 31, 2012
Enrollment
200 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease